<DOC>
	<DOCNO>NCT01403116</DOCNO>
	<brief_summary>The purpose study determine safety efficacy oral testosterone undecanoate formulation use testosterone-replacement therapy men low testosterone .</brief_summary>
	<brief_title>Safety Efficacy Trial Oral Testosterone Undecanoate ( TU ) Hypogonadal Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Eunuchism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Serum testosterone less equal 300 ng/dL two occasion within one week ( may wash previous oral , topical buccal testosterone therapy ) Significant intercurrent disease type , particular liver , kidney , uncontrolled poorly control heart disease , psychiatric illness Recent history stroke , include transient ischemic attack Untreated , sever obstructive sleep apnea . Hematocrit &lt; 35 % &gt; 48 Serum transaminase &gt; 2 time upper limit normal , serum bilirubin &gt; 2.0 mg/dL serum creatinine &gt; 2.0 mgk/dL BMI &gt; equal 36 Stable dos lipidlowering medication le 3 month Stable dos oral medication diabetes less 2 month Abnormal prostate DRE [ palpable nodule ( ) ] , elevate PSA ( &gt; 4 ng/mL ) , IPSS score &gt; equal 19 point . History breast cancer Use dietary supplement saw palmetto phytoestrogens use dietary supplement may increase serum testosterone within previous 4 week Known malabsorption syndrome and/or current treatment oral lipase inhibitor History abuse alcohol drug substance within previous 2 year Current use antiandrogens , estrogen , oral CYP3A4 inducer inhibitor , longacting opioid analgesic Receipt drug part research study within 30 day initial dose administration study . Blood donation within 12 week period initial study dose .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>testosterone</keyword>
	<keyword>male hypogonadism</keyword>
	<keyword>low testosterone</keyword>
</DOC>